Amy Morris

491 total citations
10 papers, 234 citations indexed

About

Amy Morris is a scholar working on Epidemiology, Dermatology and Oncology. According to data from OpenAlex, Amy Morris has authored 10 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Dermatology and 3 papers in Oncology. Recurrent topics in Amy Morris's work include Acne and Rosacea Treatments and Effects (3 papers), Nail Diseases and Treatments (2 papers) and Neonatal and Maternal Infections (2 papers). Amy Morris is often cited by papers focused on Acne and Rosacea Treatments and Effects (3 papers), Nail Diseases and Treatments (2 papers) and Neonatal and Maternal Infections (2 papers). Amy Morris collaborates with scholars based in United States and United Kingdom. Amy Morris's co-authors include Seth Hetherington, Barry Kapik, Patricia Westmoreland, Michael H. Gold, Yin Liu, Michael Graeber, David M. Pariser, Karen Kesler, Robert L. Schelonka and Barry T. Bloom and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Pediatrics and Antiviral Research.

In The Last Decade

Amy Morris

10 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Morris United States 7 109 72 59 58 46 10 234
Ramona Businger Germany 12 87 0.8× 58 0.8× 13 0.2× 63 1.1× 13 0.3× 18 268
Heidi Carroll Australia 7 29 0.3× 43 0.6× 81 1.4× 27 0.5× 19 0.4× 11 214
Anna Sara Navazio Italy 6 33 0.3× 26 0.4× 23 0.4× 40 0.7× 15 0.3× 11 136
Antonin Weckel United States 10 80 0.7× 48 0.7× 71 1.2× 52 0.9× 87 1.9× 14 266
Hesham Basma United States 9 186 1.7× 50 0.7× 6 0.1× 53 0.9× 212 4.6× 9 355
Parisa Shiri Aghbash Iran 11 191 1.8× 132 1.8× 10 0.2× 103 1.8× 13 0.3× 31 410
Sebastian Stentzel Germany 9 121 1.1× 29 0.4× 17 0.3× 105 1.8× 12 0.3× 11 276
Alexandre Vargas Schwarzbold Brazil 7 112 1.0× 107 1.5× 12 0.2× 20 0.3× 18 0.4× 20 210
Rúbia Anita Ferraz Santana Brazil 9 118 1.1× 104 1.4× 8 0.1× 31 0.5× 54 1.2× 17 235
Paulina Nowak Poland 5 296 2.7× 64 0.9× 5 0.1× 103 1.8× 12 0.3× 6 429

Countries citing papers authored by Amy Morris

Since Specialization
Citations

This map shows the geographic impact of Amy Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Morris more than expected).

Fields of papers citing papers by Amy Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Morris. The network helps show where Amy Morris may publish in the future.

Co-authorship network of co-authors of Amy Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Morris. A scholar is included among the top collaborators of Amy Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Morris. Amy Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kaufman, David, et al.. (2014). Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety. Early Human Development. 90. S87–S90. 12 indexed citations
2.
Pentikis, Helen S., Mark Matson, George Atiee, et al.. (2011). Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers. Antimicrobial Agents and Chemotherapy. 55(6). 2847–2854. 33 indexed citations
3.
Matson, Mark, et al.. (2009). A Study of the Safety and Pharmacokinetics of Multiple Ascending Doses of FV-100 in Healthy Subjects. Antiviral Research. 82(2). A49–A49. 2 indexed citations
4.
Pariser, David M., Patricia Westmoreland, Amy Morris, et al.. (2009). Long-Term Safety and Efficacy of a Unique Fixed-Dose Combination Gel of Adapalene 0.1% and Benzoyl Peroxide 2.5% for the Treatment of Acne Vulgaris. Journal of the Dermatology Nurses’ Association. 1(2). 146–146. 8 indexed citations
5.
Matson, Mark, et al.. (2009). A Study of the Safety and Pharmacokinetics of Single and Multiple Doses of FV-100 in Subjects 65 Years and Over. Antiviral Research. 82(2). A49–A49. 1 indexed citations
6.
Boehlecke, Brian, et al.. (2008). A Single Accelerating Dose Study to Evaluate Safety and Pharmacokinetics (PK) of FV-100 in Healthy Subjects. Antiviral Research. 78(2). A32–A32. 4 indexed citations
7.
Burchfield, David J., Barry T. Bloom, Mark J. Polak, et al.. (2007). Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants. The Journal of Pediatrics. 151(3). 260–265.e1. 114 indexed citations
8.
Pariser, David M., Patricia Westmoreland, Amy Morris, et al.. (2007). Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.. PubMed. 6(9). 899–905. 38 indexed citations
9.
Riker, Adam I., et al.. (2006). Current surgical management of melanoma. Expert Review of Anticancer Therapy. 6(11). 1569–1583. 9 indexed citations
10.
Morris, Amy, et al.. (1991). Cutaneous malignant melanoma: audit of the diagnostic process.. PubMed. 73(4). 248–52. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026